Back to top
more

HCA Healthcare (HCA)

(Real Time Quote from BATS)

$399.17 USD

399.17
560,013

-4.26 (-1.06%)

Updated Sep 17, 2024 02:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (3 out of 251)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

HCA Holdings (HCA) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, HCA Holdings (HCA) closed at $140.29, marking a +1.85% move from the previous day.

Community Health Down 16% in a Year: Can it Bounce Back?

by Zacks Equity Research

Community Health (CYH) suffers from high debt and low patient volumes, growth strategies is likely to restore its profitability.

The Zacks Analyst Blog Highlights: Berkshire Hathaway, AbbVie, Booking, HCA and Kimberly-Clark

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Berkshire Hathaway, AbbVie, Booking, HCA and Kimberly-Clark

Mark Vickery headshot

Top Research Reports for Berkshire Hathaway, AbbVie & Booking Holdings

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), AbbVie (ABBV) and Booking Holdings (BKNG).

HCA Holdings (HCA) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, HCA Holdings (HCA) closed at $143.95, marking a +1.64% move from the previous day.

The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing

by Zacks Equity Research

The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing

HCA (HCA) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

HCA (HCA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter

by Zacks Equity Research

The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter

Tirthankar Chakraborty headshot

5 Top Stocks to Make the Most of a Divided Congress

by Tirthankar Chakraborty

Gridlock in Washington bodes well for healthcare and defense stocks, which calls for investing in such a space for the time being.

Acadia Healthcare (ACHC) Misses on Q3 Earnings, Trims View

by Zacks Equity Research

Acadia Healthcare's (ACHC) Q3 earnings missed estimates and declined year over year on increase in expenses.

Tirthankar Chakraborty headshot

Election Day 2018: Here Are the Winners & Losers

by Tirthankar Chakraborty

One of the most awaited midterm elections in American history is upon us. Let's thus look at the sectors most likely to be impacted by the election results.

Has HCA Healthcare (HCA) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (HCA) Outperforming Other Medical Stocks This Year?

HCA Healthcare's (HCA) Q3 Earnings Beat Estimates, Up Y/Y

by Zacks Equity Research

HCA Healthcare's (HCA) Q3 earnings improve on the back of rising admissions.

HCA Holdings (HCA) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

HCA (HCA) delivered earnings and revenue surprises of 11.92% and 1.46%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Are Investors Undervaluing HCA Holdings (HCA) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

What's in the Cards for HCA Healthcare (HCA) in Q3 Earnings?

by Zacks Equity Research

HCA Healthcare's (HCA) Q3 results are likely to be aided by strong revenues, driven by higher admissions.

HCA Holdings (HCA) Q3 Earnings Preview: What's in the Cards?

by Zacks Equity Research

HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is HCA Healthcare (HCA) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (HCA) Outperforming Other Medical Stocks This Year?

Why HCA (HCA) Could Beat Earnings Estimates Again

by Zacks Equity Research

HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

MEDNAX Buys Radiology Specialists to Expand Business

by Zacks Equity Research

MEDNAX (MD) boosts its radiology business with the acquisition of Radiology Specialists.

    Community Health's (CYH) Subsidiary to Clear Fraud Charges

    by Zacks Equity Research

    Community Health Systems' (CYH) arm to settle whistleblower lawsuits alleging a wide-ranging misconduct in emergency rooms.

      Has HCA Healthcare (HCA) Outpaced Other Medical Stocks This Year?

      by Zacks Equity Research

      Is (HCA) Outperforming Other Medical Stocks This Year?

        Should Value Investors Pick HCA Healthcare (HCA) Stock Now?

        by Zacks Equity Research

        Let's see if HCA Healthcare, Inc. (HCA) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

          Zacks.com highlights: G-III Apparel Group, HCA Healthcare, US Ecology, Penumbra and North American Construction Group

          by Zacks Equity Research

          Zacks.com highlights: G-III Apparel Group, HCA Healthcare, US Ecology, Penumbra and North American Construction Group

            Brave Market Volatility With These 5 Low-Beta Stocks

            by Zacks Equity Research

            We create a strategy that shows less risky stocks could also be rewarding if some parameters are considered.